Skip to main content
Premium Trial:

Request an Annual Quote

Gen InCode: Paul Foulger

Gen InCode, an Oxford, UK-based company specializing in AI-powered genetic risk assessment for cardiovascular disease, has appointed Paul Foulger as CFO. Foulger previously served as group finance director at EKF Diagnostics, and is currently a non-executive director of Arcis Biotechnology and Autoclenz. He has also previously served as finance director at NovaBiotics, Elsevier Science, Venn Life Sciences, and PredictImmune, among other companies.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.